| Unilever | |
|---|---|
| Ben & Jerry's New Flavor Gives Unilever a Headache: Zev Chafets | 7/25/2021 |
| Unilever’s $68 Billion Bid for GSK Unit Marks Health Pivot | 1/17/2022 |
| Unilever to Sell Lipton Tea Owner to CVC for $5.1 Billion | 11/17/2021 |
| ‘Please Don’t:’ Analysts Scorn Unilever’s Takeover Ambitions | 1/17/2022 |
| Glaxo Rejects $68 Billion Unilever Bid for Consumer Business | 1/15/2022 |
| Unilever Plans Thousands of Job Cuts as Peltz Builds Stake | 1/24/2022 |
| Unilever Gains After Activist Investor Peltz Builds Stake | 1/24/2022 |
| Unilever Sees Toughest Inflation Since 2008 Financial Crisis | 7/22/2022 |
| Unilever Is Said to Weigh Raising Offer for Glaxo Consumer Unit | 1/16/2022 |
| Unilever CEO Misses Out on Advil Just as He May Need It | 1/20/2022 |
| Unilever Shares Jump as Peltz on Board Seen Spurring Change | 5/31/2022 |
| Israel’s Battle With Unilever's Ben & Jerry’s Heats Up: Eli Lake | 11/14/2021 |
| N.Y. State to Sell Unilever Stake on Ben & Jerry’s Israel Stance | 10/28/2021 |
| Unilever Goes All-Out on Pricing as Inflation Accelerates | 10/20/2021 |
| Unilever to Cut 15% of Senior Managers as Peltz Adds Pressure | 1/25/2022 |
| Activist Hedge Fund Trian Builds Stake in Unilever: FT | 1/23/2022 |
| Unilever’s Inflation Warning Piles More Pressure on CEO Jope | 2/10/2022 |
| Unilever Rules Out Raising $68 Billion Glaxo Consumer Bid | 1/19/2022 |
| Terry Smith Slams Unilever Management After Glaxo Bid Fails | 1/20/2022 |
| Ben & Jerry’s Sues Unilever to Stop Israel Ice Cream Deal | 7/6/2022 |
AnalystSolutions respects your privacy and will never share your information with others. You can remove yourself from any distribution with one click.
We offer free full versions of our content for evaluation purposes (valued at over $700) to professionals holding the following roles:
You will receive:
To ensure a quick verification of your role above (usually within one business day), please provide the email address issued by your organization.
You will be directed to our 20-question quiz to determine if you possess the skills of a seasoned equity research analyst. Please provide a valid email address to receive your results (your email address remains confidential within AnalystSolutions):
We will attempt to reply to you within one business day based upon the responses to our questions below.
You will be directed to the FREE SAMPLE EDITION of our GAMMA PI™ Equity Research Analyst Self-Assessment. Please provide a valid email address to receive your results (your email address remains confidential within AnalystSolutions).
Please answer these questions to help James Valentine prepare for your call (he will keep your responses confidential):
Please answer these questions to help James Valentine prepare for your call (he will keep your responses confidential):
Please answer these questions to help James Valentine prepare for your call (he will keep your responses confidential)
Please answer these questions to help James Valentine prepare for your call (he will keep your responses confidential)